Terumo Corporation (ADR)
General ticker "TRUMY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $26.8B (TTM average)
Terumo Corporation (ADR) does not follow the US Stock Market performance with the rate: -23.4%.
Estimated limits based on current volatility of 1.9%: low 14.30$, high 14.85$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-09-30, amount 0.09$ (Y1.22%)
- Current price 11.6% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [16.72$, 23.20$]
- 2026-03-31 to 2027-03-31 estimated range: [17.82$, 24.59$]
Financial Metrics affecting the TRUMY estimates:
- Positive: with PPE of 35.8 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 15.22
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 6.01
- Negative: Industry operating profit margin (median), % of -6.19 <= 2.97
- Positive: Inventory ratio change, % of -1.59 <= -0.75
- Negative: Operating cash flow per share per price, % of 5.10 <= 6.82
- Positive: 0 < Industry operating cash flow per share per price (median), % of 0.78
- Positive: Shareholder equity ratio, % of 74.85 > 63.39
Short-term TRUMY quotes
Long-term TRUMY plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥820,209.00MM | ¥921,863.00MM | ¥1,036,171.00MM |
| Operating Expenses | ¥702,877.00MM | ¥781,767.00MM | ¥878,503.00MM |
| Operating Income | ¥117,332.00MM | ¥140,096.00MM | ¥157,668.00MM |
| Non-Operating Income | ¥-1,195.00MM | ¥733.00MM | ¥-3,094.00MM |
| Interest Expense | ¥4,016.00MM | ¥2,775.00MM | ¥6,247.00MM |
| R&D Expense | ¥61,600.00MM | ¥0.00MM | ¥0.00MM |
| Income(Loss) | ¥116,137.00MM | ¥140,829.00MM | ¥154,574.00MM |
| Taxes | ¥26,811.00MM | ¥34,455.00MM | ¥37,595.00MM |
| Profit(Loss)* | ¥89,325.00MM | ¥106,374.00MM | ¥116,978.00MM |
| Stockholders Equity | ¥1,111,063.00MM | ¥1,327,090.00MM | ¥1,368,535.00MM |
| Inventory | ¥249,618.00MM | ¥286,599.00MM | ¥294,385.00MM |
| Assets | ¥1,602,225.00MM | ¥1,831,402.00MM | ¥1,828,393.00MM |
| Operating Cash Flow | ¥117,536.00MM | ¥146,330.00MM | ¥210,802.00MM |
| Capital expenditure | ¥72,173.00MM | ¥78,774.00MM | ¥82,365.00MM |
| Investing Cash Flow | ¥-59,121.00MM | ¥-81,472.00MM | ¥-82,481.00MM |
| Financing Cash Flow | ¥-86,559.00MM | ¥-62,079.00MM | ¥-108,766.00MM |
| Earnings Per Share** | ¥59.50 | ¥71.50 | ¥79.01 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.